Last reviewed · How we verify

NCT04138953

Cortical Contributions to Motor Sequence Learning

Completed NA Results posted Last updated 28 August 2024
What this trial tests

NA trial testing Transcranial Magnetic Stimulation (TMS) in Brain Injuries in 64 participants. Completed in 4 August 2023.

Timeline
5 December 2019
Primary endpoint
4 August 2023
4 August 2023

Quick facts

Lead sponsorEmory University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment64
Start date5 December 2019
Primary completion4 August 2023
Estimated completion4 August 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Emory University

Who can join

Adults 18 to 85, any sex, with Brain Injuries. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Serial Reaction Time Task (SRTT) Performance Primary · Pre-test (baseline), Post-test (training usually lasts for 3 hours), Retention Test (30 mins following training)

The SRTT involves pressing a key that corresponds to a target square presented on a monitor. Sequenced skill (SS) is calculated by subtracting the response time of sequenced key presses from random key presses within and across a test block. An increase in SS value indicates an increase in sequenced skill and is a preferable result.

SS Pre-test
GroupValue95% CI
Sham TMS31± 38
TMS Over Primary Motor Cortex (M1)35± 19
TMS Over Premotor Cortex (PMC)38± 24
SS Post-test
GroupValue95% CI
Sham TMS24± 21
TMS Over Primary Motor Cortex (M1)30± 22
TMS Over Premotor Cortex (PMC)17± 23
SS Retention Testing
GroupValue95% CI
Sham TMS31± 25
TMS Over Primary Motor Cortex (M1)40± 23
TMS Over Premotor Cortex (PMC)29± 11
Cortical Excitability Measured by Motor Evoked Potentials (MEPs) Secondary · Pre-test (baseline), Post-test (training usually lasts for 3 hours)

Evaluate the effect of sequence learning on motor cortical excitability. Cortical excitability will be indexed by peak-to-peak amplitudes of transcranial magnetic stimulation (TMS)-evoked electromyographic responses in the hand contralateral to the motor cortex targeted by TMS quantified before and after training. An increase in MEPs indicates neural plasticity due to increases in skill.

MEP Amplitude Pre-test
GroupValue95% CI
Sham TMS1.03± 0.97
TMS Over Primary Motor Cortex (M1)1.29± 1.22
TMS Over Premotor Cortex (PMC)0.45± 0.37
MEP Amplitude Post-test
GroupValue95% CI
Sham TMS1.15± 1.03
TMS Over Primary Motor Cortex (M1)1.37± 1.24
TMS Over Premotor Cortex (PMC)0.51± 0.53

Sponsor's own description

The long-term objective initiated with this study is to determine which brain areas functionally contribute to learning a motor skill. The primary hypothesis of this trial is that premotor cortex (PMC) is necessary to learn a new motor skill. Participants may undergo a MRI scan to acquire a structural image of their brain to target noninvasive stimulation, using transcranial magnetic stimulation (TMS) to one of two brain areas: PMC or primary motor cortex (M1). A third group of individuals will undergo a placebo stimulation protocol. For all three groups, stimulation will be used to create a transient 'virtual lesion' during motor skill training. Temporarily disrupting the normal activity of these brain regions during training will allow us to determine which regions are causally involved in learning a new motor skill. The primary outcome measure will be the change in skill after training in each group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcranial Magnetic Stimulation (TMS)

Trials testing the same drug.

Other recruiting trials for Brain Injuries

Currently open trials in the same condition.

Other Emory University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04138953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing